QT interval

Related by string. QT intervals * Qt . QTS . qt . QTD : thorough QT . Qt SDK . Thorough QT . Usual QT . Thorough QT studies / Interval . Intervals . INTERVAL . intervals : confidence interval #.#-#.# . confidence interval CI . assay intervals . interval grading * QT interval prolongation . prolonged QT interval . prolong QT interval . prolonged QT intervals . corrected QT interval . cardiac QT interval *

Related by context. All words. (Click for frequent words.) 78 QTc interval 75 QT intervals 69 QTc 67 QT prolongation 66 corrected QT interval 66 prolonged QT interval 65 torsade de pointes 65 QTc intervals 65 Tasigna prolongs 64 torsades de pointes 64 QTc prolongation 63 MULTAQ 63 sinus tachycardia 62 repolarization 61 ventricular arrhythmia 61 LATUDA 61 activated partial thromboplastin 61 thromboembolic events 61 RISPERDAL R 61 induce orthostatic hypotension 60 left ventricular dysfunction 60 QT syndrome 60 Digoxin 60 ventricular repolarization 60 β blockers 60 coadministration 60 extrapyramidal symptoms 60 Hypotension 59 serum phosphorous 59 INVEGA ® 59 Paliperidone 59 Torsades de Pointes 59 cardiac repolarization 59 APTIVUS r 59 severe renal impairment 59 QRS interval 59 thrombotic events 59 hepatotoxicity 59 Dronedarone 59 SUSTENNA TM 59 alpha blocker 59 MEVACOR 59 recurrent VTE 59 QRS duration 58 anti androgen 58 MAO inhibitors 58 serum calcium levels 58 ziprasidone 58 quinidine 58 arrhythmias 58 QT interval prolongation 58 carotid IMT 58 ventricular arrhythmias 58 antiarrhythmic 58 pimozide 58 DAPT 58 cardiac conduction 58 flecainide 58 PR interval prolongation 58 tibolone 58 paroxysmal AF 58 alteplase 58 Carvedilol 58 ropinirole 58 levodopa therapy 58 dyskinesias 58 carotid intima media 58 microvascular disease 58 ventricular tachyarrhythmias 58 lumbar spine BMD 58 serum potassium levels 58 QT QTc 58 LHRH agonists 58 VIIBRYD 57 BYSTOLIC 57 cardiac toxicity 57 dronedarone 57 warfarin therapy 57 ABCB1 57 cerebrovascular events 57 lumiracoxib 57 cardiac troponin 57 milrinone 57 ventricular tachyarrhythmia 57 HMG CoA reductase inhibitors 57 BANZEL 57 ICD shocks 57 immunosuppressant therapy 57 Venlafaxine 57 NMDA receptor antagonists 57 efalizumab 57 acting beta agonists 57 primidone 57 NATRECOR ® 57 tachyarrhythmias 57 intraventricular 57 eptifibatide 57 neurologic progression 57 monoamine oxidase inhibitors 57 metabolic acidosis 57 myocardial ischemia 57 Ventricular Tachycardia 57 pharmacokinetic interactions 57 rhythm disturbances 57 loop diuretics 57 EFFEXOR XR 57 abnormal heartbeats 57 adrenal suppression 57 gonadotropin releasing hormone 57 preserved ejection fraction 57 INVEGA ™ 57 glutamate neurotransmission 57 ventricular tachycardia 57 hypoperfusion 57 prothrombin 57 ventricular fibrillation VF 57 biventricular pacing 57 T wave alternans 57 MAO inhibitor 57 metabolic parameters 57 citalopram Celexa 57 intima media thickness 56 ictal 56 Tasimelteon 56 arrhythmogenic 56 receptor subtype 56 fluvastatin 56 fluoxetine Prozac 56 Topiramate 56 nephrotoxicity 56 anticoagulation therapy 56 ADPKD 56 hyperglycaemia 56 serum phosphate 56 thromboembolism 56 tranylcypromine 56 tardive dyskinesia TD 56 tricyclic antidepressants TCAs 56 paricalcitol 56 INVEGA R 56 LQTS 56 thioridazine 56 platelet aggregation 56 left ventricular hypertrophy 56 angina pectoris 56 phosphodiesterase type 5 56 dopamine agonists 56 cytopenias 56 haloperidol Haldol 56 PRADAXA 56 antiarrhythmic drugs 56 cardiac resynchronization 56 Brugada syndrome 56 rate variability HRV 56 Adalimumab 56 term potentiation 56 beta agonists 56 INVEGA 56 COREG 56 aspirin clopidogrel 56 D dimer 56 LVEF 56 antiandrogens 56 angiotensin converting enzyme 56 teriparatide 56 Hydroxyurea 56 Unstable angina 56 ACTOplus met 56 sotalol 56 selective NSAIDs 56 autoregulation 56 term potentiation LTP 56 prolonged QT intervals 56 prednisone prednisolone 56 anticholinergics 56 poor metabolizers 56 lacosamide 56 fibrinolysis 56 vecuronium 56 systolic ejection 56 Oral mucositis 56 paroxetine Paxil 56 DULERA 56 ranolazine 56 severe neutropenia 56 liver toxicity 56 Lp PLA2 56 androgen deprivation 56 NATRECOR R 55 corticosteroid therapy 55 allopregnanolone 55 dobutamine 55 QRS width 55 paroxetine sertraline 55 VT VF 55 renal dysfunction 55 dyssynchrony 55 thyrotoxicosis 55 hyperkalemia 55 EXJADE 55 GnRH agonist 55 abdominal adiposity 55 stable angina 55 CK MB 55 PRADAXA #mg 55 tolvaptan 55 Diovan HCT 55 MAOI 55 azacitidine 55 insulin detemir 55 β blocker 55 telomere lengths 55 oxcarbazepine 55 hyperprolactinemia 55 prolactin levels 55 GnRH agonists 55 VAPRISOL 55 potassium sparing diuretics 55 Dasatinib 55 TEAEs 55 MAOIs 55 Amiodarone 55 bradycardia 55 nelfinavir 55 electrical conduction 55 thromboembolic 55 dopaminergic therapy 55 reboxetine 55 Riluzole 55 long QT syndrome 55 postoperative AF 55 glucocorticoids 55 serum BDNF 55 Ejection Fraction 55 electrocardiographic 55 diastolic function 55 Spironolactone 55 sinus bradycardia 55 orthostatic hypotension 55 levodopa 55 endothelial dysfunction 55 spironolactone 55 thromboembolic complications 55 L dopa 55 venlafaxine Effexor 55 tachycardias 55 narrow QRS 55 platelet activation 55 Aortic Stenosis 55 androgen suppression 55 conventional antipsychotics 55 electrophysiologic 55 IFN beta 55 ventricular fibrillation 55 neuronal plasticity 55 anti arrhythmic drugs 55 Cmax 55 oral antidiabetic medication 55 lactate dehydrogenase LDH 55 hypoglycemic episodes 55 antiplatelet drugs 55 serum phosphate levels 55 mammographic density 55 cholinergic tone 55 serum sodium 55 hematological parameters 55 neuroleptics 55 fasting glucose levels 55 Symbyax 55 AVANDIA 55 isoenzyme 55 hypokalemia hypomagnesemia 55 adrenocorticotropic hormone 55 ATACAND 55 aldosterone antagonists 55 antiarrhythmic drug 55 baroreceptors 55 serotonin reuptake inhibitors 55 inotropes 55 irbesartan 55 beta blocker therapy 55 left ventricular systolic 55 Paxil paroxetine 55 pyridostigmine 55 Bosentan 55 variant angina 55 renal toxicity 55 serum creatinine 55 asymptomatic carotid stenosis 54 KETEK 54 calcium channel 54 rt PA 54 ursodeoxycholic acid 54 bisoprolol 54 sustained ventricular tachycardia 54 reperfusion therapy 54 mechanical dyssynchrony 54 venlafaxine 54 transaminase levels 54 dopamine agonist 54 adult chronic ITP 54 aPTT 54 exhaled nitric oxide 54 menstrual bleeding 54 cardiac resynchronization therapy 54 periprocedural 54 platelet inhibition 54 adiponectin levels 54 carotid atherosclerosis 54 endometrial thickness 54 renal insufficiency 54 divalproex sodium 54 tricyclic antidepressants 54 PSADT 54 telomere length 54 moderate renal impairment 54 sulphonylureas 54 Duloxetine 54 cerebral ischemia 54 HPA axis 54 tirofiban 54 hypocalcemia 54 dopamine partial agonist 54 rCBF 54 IELT 54 renal impairment 54 ximelagatran 54 glitazones 54 anticlotting drugs 54 abatacept 54 FASLODEX 54 virologic response 54 virologic failure 54 bone resorption 54 calculated creatinine clearance 54 anticholinergic drugs 54 fluid overload 54 intraocular pressure IOP 54 antipsychotic efficacy 54 direct thrombin inhibitors 54 candesartan 54 platelet reactivity 54 warfarin Coumadin 54 reflux symptoms 54 concomitant medications 54 cerebral vasospasm 54 atrial arrhythmias 54 SAPHRIS 54 serum aminotransferase levels 54 ICDs implanted 54 oral antidiabetic drugs 54 oral anticoagulation 54 CRT Ds 54 Vimpat R 54 systolic dysfunction 54 EVISTA 54 troponin T 54 olmesartan 54 cilostazol 54 NPH insulin 54 PRISTIQ 54 quetiapine Seroquel 54 tolterodine 54 ULORIC 54 tocilizumab 54 ventricular tachycardia VT 54 INVEGA ® SUSTENNA ® 54 antiplatelet therapy 54 VA# [002] 54 potentiation 54 atrioventricular block 54 verapamil 54 MMSE score 54 ACh 54 upper gastrointestinal bleeding 54 AZILECT 54 hyperalgesia 54 HER2 expression 54 K ras mutations 54 crossclamp 54 Nesiritide 54 inotropic 54 inhaled anticholinergics 54 NMDA antagonist 54 MADIT II 54 myoclonus 54 ACE Inhibitors 54 decitabine 54 T2DM 54 leflunomide 54 intravenous cyclophosphamide 54 Anticoagulants 54 salmeterol inhalation powder 54 vasoconstrictor 54 non valvular atrial 54 heterozygous FH 54 pressor response 54 tissue plasminogen activator tPA 54 Telmisartan 54 fosamprenavir 54 denervation 54 atrial pacing 54 rhythm abnormalities 54 Akt activation 54 asystole 54 clopidogrel Plavix 54 symptomatic VTE 54 ARIXTRA 54 telomerase activity 54 amisulpride 54 Fibrates 54 urate lowering therapy 54 acting insulin analogues 54 resynchronization therapy 54 troponin 53 heart arrhythmias 53 radiographic progression 53 colorectal adenoma 53 PGI2 53 CGRP 53 anakinra 53 vasodilators 53 sertraline Zoloft 53 thromboprophylaxis 53 hypokalemia 53 intravenous bisphosphonates 53 5 HTTLPR 53 hyperphenylalaninemia HPA due 53 myopathy rhabdomyolysis 53 tricyclic antidepressant 53 anticoagulant warfarin 53 cardiac contractility 53 Rivaroxaban 53 cTnT 53 erratic heartbeats 53 cardiotoxicity 53 Venous thromboembolism 53 eplerenone 53 vandetanib 53 Proteinuria 53 baclofen 53 TGF beta signaling 53 cholinesterase inhibitors 53 flutamide 53 dysfunction LVSD 53 Thrombocytopenia 53 antiarrhythmic medications 53 mycophenolate mofetil 53 contractile function 53 QTcF 53 Lenalidomide 53 warfarin 53 Valproate 53 STRIDE PD 53 epoetin beta 53 glycated hemoglobin levels 53 bezafibrate 53 monoamine oxidase inhibitors MAOIs 53 opioid analgesia 53 clot dissolving drug 53 sorafenib Nexavar 53 macrovascular disease 53 beta adrenergic 53 serum creatinine levels 53 neuromuscular blockade 53 foveal thickness 53 afterload 53 AV node 53 parkinsonian symptoms 53 nifedipine 53 ZOLINZA 53 oral antidiabetes 53 hydralazine 53 Systolic 53 oral anticoagulant 53 PREZISTA r 53 pentoxifylline 53 glycogen metabolism 53 Celecoxib 53 intravitreal injections 53 lactic acidosis 53 safinamide 53 electrical cardioversion 53 heparin induced thrombocytopenia 53 quetiapine 53 anticoagulation 53 acute PAO 53 antimuscarinic 53 persistent pulmonary hypertension 53 nicardipine 53 recombinant tissue plasminogen 53 sinus node 53 cardiac dysfunction 53 vasomotor symptoms 53 interferon therapy 53 serum estradiol 53 sodium valproate 53 gout flares 53 threatening arrhythmias 53 AGILECT R 53 inhaled budesonide 53 INTEGRILIN R 53 fulvestrant 53 clomipramine 53 #mg doses [002] 53 glucocorticoid therapy 53 tiagabine 53 isoproterenol 53 EEG abnormalities 53 growth hormone secretion 53 ipsilateral stroke 53 COX2 53 NUCYNTA R 53 pioglitazone HCl 53 adrenal insufficiency 53 biphasic 53 abnormal rhythms 53 atheroma volume 53 hypoglycaemic episodes 53 aripiprazole 53 anticonvulsants 53 teriflunomide 53 vascular inflammation 53 unstable angina pectoris 53 antihypertensive medications 53 idarubicin 53 transthoracic 53 PROMACTA 53 etomidate 53 creatinine levels 53 candesartan cilexetil 53 luteal phase 53 selegiline 53 tonic clonic seizures 53 status epilepticus 53 perioperatively 53 cardioembolic stroke 53 androgen suppression therapy 53 dopamine antagonists 53 Zoloft sertraline 53 neostigmine 53 benazepril 53 LEXIVA 53 impair fertility 53 PTPN# 53 triiodothyronine 53 subclinical hypothyroidism 53 PTH secretion 53 beta blocker 53 silent ischemia 53 beta blockers 53 Pramipexole 53 fluvastatin Lescol 53 thickness IMT 53 nadolol 53 Dabigatran 53 bisphosphonate therapy 53 endometrial hyperplasia 53 sulfasalazine 53 hypercalcemia 53 airflow obstruction 53 dosage regimens 53 atorvastatin Lipitor 53 typical antipsychotics 53 pioglitazone 53 mitochondrial respiration 53 inhaled steroid 53 optic neuropathy 53 hsCRP 53 GH secretion 53 erlotinib Tarceva 53 Corticosteroids 53 serum cholesterol 53 CrCl 53 Febrile neutropenia 53 neuroleptic 53 AV conduction 53 angiotensin converting enzyme inhibitor 53 statin medications 53 pulmonary exacerbations 53 olanzapine 53 proapoptotic 53 aldosterone antagonist 53 thrombus aspiration 53 channel blockers 53 benign gastric ulcers 53 pramipexole 53 Ivabradine 53 ventricular dyssynchrony 53 hepatic function 53 neuropsychiatric symptoms 53 dyskinesia 53 MADRS score 53 acarbose 53 anticoagulant therapy 53 intensive statin therapy 53 antiplatelet medications 53 OSAHS 53 transaminases 53 thiazides 52 flow mediated dilation 52 cholinesterase inhibitor 52 lispro 52 primary aldosteronism 52 atherosclerotic disease 52 Atrial 52 COPAXONE ® 52 thiazide 52 renal artery stenosis 52 hemorrhagic complications 52 subclinical hyperthyroidism 52 placebo controlled trials 52 electrocardiogram EKG 52 doxazosin 52 Erythropoietic therapies may 52 nocturnal hypoglycaemia 52 antidepressant efficacy 52 anti coagulant therapy 52 leukotriene receptor antagonist 52 GP IIb IIIa inhibitors 52 IL 1ß 52 atherothrombotic events 52 microalbuminuria 52 Betaferon ® 52 thiazide diuretic 52 SSRIs selective serotonin 52 bypass graft CABG surgery 52 solifenacin 52 tamsulosin 52 Tardive dyskinesia 52 serotonin receptor 52 kainate 52 defibrillator implant 52 Ventricular fibrillation 52 proto oncogene 52 glycosylated hemoglobin HbA1c 52 antiplatelet agents 52 Sinemet 52 rtPA 52 fibrillation 52 APTIVUS 52 RLAI 52 procalcitonin 52 antiapoptotic 52 Generalized anxiety disorder 52 amiodarone 52 heavy menstrual bleeding 52 pioglitazone Actos 52 decompensated heart failure 52 cediranib 52 allopurinol 52 cabazitaxel 52 thiazide diuretics 52 insulin sensitizers 52 immunosuppressive regimen 52 Avandia Actos 52 cardiac resynchronisation therapy 52 icatibant 52 clinically insignificant 52 #mg dose [001] 52 tardive dyskinesia 52 calcitriol 52 Focalin XR 52 LMWH 52 antiarrhythmics 52 tyrosine phosphorylation 52 airway inflammation 52 selective serotonin reuptake inhibitors 52 albumin excretion rate 52 coxibs 52 repetitive transcranial magnetic stimulation 52 angiotensin converting enzyme ACE 52 dosing interval 52 aromatase inhibitor therapy 52 Glucocorticoids 52 SCN5A 52 intracerebral hemorrhage 52 prostate TURP 52 claudication 52 hypothalamic pituitary adrenal axis 52 Beta blockers 52 dysrhythmias 52 antioxidant supplementation 52 clozapine Clozaril 52 ACEIs 52 artery stenosis 52 systolic hypertension 52 Nonsteroidal anti inflammatory 52 gastric acid secretion 52 clusterin 52 xanthine oxidase inhibitor 52 losartan 52 metformin sulfonylurea 52 arterial stiffness 52 AZILECT R 52 phenobarbital phenytoin 52 albumin excretion 52 lysophosphatidic acid 52 elevated triglyceride levels 52 calcium homeostasis 52 cardiovascular morbidity 52 omeprazole Prilosec 52 cyclooxygenase 2 52 ventricular pacing 52 bi ventricular pacing 52 systolic pressure 52 vorinostat 52 indomethacin 52 rosuvastatin #mg 52 chlorthalidone 52 SERCA2a 52 immunoreactivity 52 pomalidomide 52 RAS blockers 52 angiotensin receptor blockers 52 thrombocytopenic patients 52 diastolic dysfunction 52 perioperative complications 52 severe hypersensitivity reactions 52 sinus node dysfunction 52 transient ischemic attack 52 hydroxychloroquine 52 phenytoin 52 thrombotic complications 52 COPAXONE R 52 Darapladib 52 Valsartan 52 catheter angiography 52 bronchial hyperresponsiveness 52 macrovascular events 52 cortical activation 52 proliferative diabetic retinopathy 52 glycemia 52 Candesartan 52 lipid levels 52 ribavirin therapy 52 bronchodilation 52 esomeprazole Nexium 52 atorvastatin #mg 52 cardiovascular disease cerebrovascular disease 52 desvenlafaxine succinate 52 serum calcium 52 adalimumab 52 inducible nitric oxide synthase 52 apneic episodes 52 antidiabetic medications 52 PSVT 52 allograft rejection 52 TGFß 52 baroreflex 52 electrocardiogram ECG 52 Ischemia 52 TAXUS Stent 52 myocardial infarction MI 52 hypnotics 52 acid suppressing 52 antihypertensive therapy 52 mutated KRAS 52 coxib 52 cardioversion 52 neurologic symptoms 52 pacemaker implantation 52 cardiovascular hospitalizations 52 airway constriction 52 Prehypertension 52 FAMPYRA 52 post operative ileus 52 progressive neurodegenerative disorder 52 digoxin 52 autonomic dysfunction 52 reinfarction 52 follicle stimulating hormone FSH 52 anogenital distance 52 antiepileptic medications 52 haemodynamic 52 armodafinil 52 Hypertrophy 52 MAXALT 52 hypotensive 52 antiplatelet agent 52 bipolar mania trials 52 MADIT CRT trial 52 antithrombotics 52 subcutaneous infusion 52 syncope 52 mitoxantrone 52 liver histology 52 RVOT 52 SCr 52 ERK1 2 52 dual antiplatelet therapy 52 LVSD 52 N methyl 52 zolmitriptan 52 myocardial fibrosis 52 ABC/3TC 52 pulmonary artery banding 52 ischemic cardiomyopathy 52 diclofenac Voltaren 52 receptor activation 52 ramelteon 52 ADAS cog 52 prodrome 52 white matter hyperintensities 52 rFVIIa 52 OGTT 52 valsartan 52 neuronal activity 52 EDARBI 52 Cimzia R 52 anti arrhythmic drug 51 nonfatal MI 51 IFRD1 51 angiotensin II receptor blockers 51 certolizumab pegol 51 IFN γ 51 glucocorticoid 51 transcranial magnetic stimulation 51 Sycrest 51 serum testosterone 51 cardiomyopathies 51 pharmacodynamic parameters 51 RISPERDAL ® 51 pCR 51 virological response 51 neurocognitive function 51 headache nasopharyngitis 51 estimated glomerular filtration 51 #mg/day [002] 51 ß1 51 streptokinase 51 6MWD 51 Restless Legs Syndrome RLS 51 angiotensin converting enzyme inhibitors 51 microglial 51 hepatic toxicity 51 Paroxetine 51 myocardial infarctions 51 Oral corticosteroids 51 systemic corticosteroid 51 risperidone Risperdal 51 tryptophan depletion 51 thienopyridine 51 postprandial glycemia 51 beta adrenergic receptor 51 ancrod 51 chronic idiopathic thrombocytopenic purpura 51 Non Steroidal Anti Inflammatory 51 incretin 51 rosiglitazone 51 myocardial infarction stroke 51 glitazone 51 intermittent claudication 51 epoetin 51 amenorrhoea 51 serum bicarbonate 51 SGS# 51 nefazodone 51 triptans 51 hemodynamically unstable 51 macrovascular 51 hematologic toxicity 51 Lamictal XR 51 Doxil ® 51 dexrazoxane 51 Levodopa 51 ventricular enlargement 51 Stent thrombosis 51 Hypertrophic cardiomyopathy 51 transcranial Doppler ultrasound 51 Low density lipoprotein 51 rotigotine 51 Thiazolidinediones 51 urinary calcium excretion 51 premenstrual syndrome PMS 51 signaling cascades 51 paroxetine 51 hypercholesterolaemia 51 mirtazapine 51 infliximab Remicade 51 postoperative mortality 51 microvascular complications 51 defibrillator CRT D 51 NSAIDs 51 depolarizing 51 cangrelor 51 DU #b 51 adipogenic 51 thromboembolic disease 51 HbA1c levels 51 LV dysfunction 51 hedgehog signaling 51 propranolol Inderal 51 partial thromboplastin 51 insulin glargine 51 nesiritide 51 KAPIDEX 51 coronary stenosis 51 left ventricular ejection 51 FASPS 51 neurite outgrowth 51 antiretroviral naive 51 IFN α 51 fibrinolytic 51 acromegalic patients 51 hepatic enzymes 51 Rasagiline 51 cortisol secretion 51 reperfusion injury 51 recurrent glioblastoma multiforme 51 F FDG PET 51 bronchoconstriction 51 hypoxemia 51 danazol 51 thyrotropin levels 51 NRG1 51 extubation 51 atypical fractures 51 Nocturia 51 NAbs 51 Propranolol 51 thyroxine 51 hemodilution 51 sildenafil Viagra 51 Hashimoto thyroiditis 51 Arrhythmias 51 abacavir 51 anticoagulant medications 51 transthyretin 51 calcineurin 51 Restenosis 51 coumadin 51 amenorrhea 51 paliperidone palmitate 51 tipranavir r 51 vasodilator 51 recurrent venous thromboembolism 51 stimulant medications 51 AZT zidovudine Retrovir 51 Natalizumab 51 mycophenolic acid 51 thrombolytic therapy 51 ReoPro 51 hypertensives 51 COPD exacerbations 51 PDE5 inhibitors 51 anxiolytics 51 idraparinux 51 TGF beta pathway 51 lovastatin 51 intravaginal ejaculatory latency 51 postoperative atrial fibrillation 51 antiplatelet 51 SNRI 51 Tylenol acetaminophen 51 neuroleptic malignant syndrome 51 bacterial prostatitis 51 noncardiac 51 serum urate levels 51 clomiphene citrate 51 PsA 51 neurodevelopmental outcome 51 metoprolol 51 abacavir lamivudine 51 asthma exacerbation 51 lipid lowering therapy 51 potentially hepatotoxic 51 intermittent hypoxia 51 octreotide 51 serum urate 51 biphosphonates 51 RAS inhibitors 51 Calorie restriction 51 adrenal function 51 atherosclerotic lesions 51 magnetic stimulation 51 albuminuria 51 carotid artery stenosis 51 Atypical antipsychotics 51 anterior uveitis 51 dopamine receptor gene 51 carotid plaque 51 Ritalin methylphenidate 51 zopiclone 51 HAQ DI 51 tachycardia 51 serotonergic 51 generalized seizures 51 contrast echocardiography 51 Treatment emergent adverse 51 selective serotonin 51 lorazepam Ativan 51 topiramate Topamax 51 TMP SMX 51 adrenalectomy 51 cerebral infarction 51 apnea hypopnea index 51 akinesia 51 clopidogrel therapy

Back to home page